Elevated serum parathormone levels are associated with myocardial iron overload in patients with β-thalassaemia major

European Journal of Haematology

Volumn 84, Issue 1, 2010, Pages 64-71

  Dimitriadou, Meropi ^a   Christoforidis, Athanasios ^a   Economou, Marina ^a   Tsatra, Ioanna ^b   Vlachaki, Efthimia ^b   Fidani, Liana ^a   Katzos, George ^a   Athanassiou Metaxa, Miranda ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b Aristotle University of Thessaloniki   (Greece)

Author keywords

Heart, iron overload; Parathormone; Thalassaemia; Vitamin D

Indexed keywords

CALCIFEDIOL; CALCITRIOL; FERRITIN; IRON; IRON CHELATING AGENT; PARATHYROID HORMONE; VITAMIN D;

ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CARDIOMYOPATHY; CHELATION THERAPY; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; HEART EJECTION FRACTION; HEART VENTRICLE EJECTION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE WALL; HUMAN; HYPERPARATHYROIDISM; IRON CHELATION; IRON INDUCED CARDIOMYOPATHY; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; SCHOOL CHILD; SYSTOLIC DYSFUNCTION; THALASSEMIA MAJOR; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ADOLESCENT; ADULT; BETA-THALASSEMIA; BLOOD TRANSFUSION; CALCIFEDIOL; CALCITRIOL; CHILD; FEMALE; FERRITINS; HUMANS; IRON; IRON OVERLOAD; MAGNETIC RESONANCE IMAGING; MALE; MYOCARDIUM; PARATHYROID HORMONE; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 72449125272     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2009.01349.x     Document Type: Article

References (43)

1. Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 2004 89 : 1187 1193.
2. Chouliaras G, Yiannoutsos CT, Berdoukas V, Ladis V. Cardiac related death in thalassaemia major: time trend and risk factors in a large greek unit. Eur J Haematol 2009 82 : 381 387.
3. Wood JC. Cardiac iron across different transfusion-dependent diseases. Blood Rev 2008 22 (Suppl. 2 S14 21.
4. Liu Y, Parkes JG, Templeton DM. Differential accumulation of non-transferrin-bound iron by cardiac myocytes and fibroblasts. J Mol Cell Cardiol 2003 35 : 505 514.
5. Ke Y, Chen YY, Chang YZ, Duan XL, Ho KP, Jiang DH, Wang K, Qian ZM. Post-transcriptional expression of dmt1 in the heart of rat. J Cell Physiol 2003 196 : 124 130.
6. + channels in iron transport and iron-overload cardiomyopathy. J Mol Med 2006 84 : 349 364.
7. + channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nat Med 2003 9 : 1187 1194.
8. Wood JC, Claster S, Carson S, Menteer JD, Hofstra T, Khanna R, Coates T. Vitamin D deficiency, cardiac iron and cardiac function in thalassaemia major. Br J Haematol 2008 141 : 891 894.
9. Anderson LJ, Holden S, Davis B, et al. Cardiovascular t2-star (t2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001 22 : 2171 2179.
10. Cohen AR, Galanello R, Pennell DJ, Cunningham MJ, Vichinsky E. Thalassemia. Hematology Am Soc Hematol Educ Program 2004 : 14 34.
11. Wood JC, Enriquez C, Ghugre N, Tyzka JM, Carson S, Nelson MD, Coates TD. Mri r2 and r2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 2005 106 : 1460 1465.
12. Bellenger NG, Francis JM, Davies CL, Coats AJ, Pennell DJ. Establishment and performance of a magnetic resonance cardiac function clinic. J Cardiovasc Magn Reson 2000 2 : 15 22.
13. Maceira AM, Prasad SK, Khan M, Pennell DJ. Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2006 8 : 417 426.
14. Maceira AM, Prasad SK, Khan M, Pennell DJ. Reference right ventricular systolic and diastolic function normalized to age, gender and body surface area from steady-state free precession cardiovascular magnetic resonance. Eur Heart J 2006 27 : 2879 2888.
15. Angelopoulos NG, Goula A, Rombopoulos G, Kaltzidou V, Katounda E, Kaltsas D, Tolis G. Hypoparathyroidism in transfusion-dependent patients with beta-thalassemia. J Bone Miner Metab 2006 24 : 138 145.
16. + channel modifiers: possible implications in iron overload. Circ Res 1999 84 : 1302 1309.
17. Oudit GY, Trivieri MG, Khaper N, Husain T, Wilson GJ, Liu P, Sole MJ, Backx PH. Taurine supplementation reduces oxidative stress and improves cardiovascular function in an iron-overload murine model. Circulation 2004 109 : 877 885.
18. Baczynski R, Massry SG, Magott M, el-Belbessi S, Kohan R, Brautbar N. Effect of parathyroid hormone on energy metabolism of skeletal muscle. Kidney Int 1985 28 : 722 727. (Pubitemid 16156311)
19. el-Belbessi S, Brautbar N, Anderson K, Campese VM, Massry SG. Effect of chronic renal failure on heart. Role of secondary hyperparathyroidism. Am J Nephrol 1986 6 : 369 375.
20. Zhang YB, Smogorzewski M, Ni Z, Massry SG. Altered cytosolic calcium homeostasis in rat cardiac myocytes in crf. Kidney Int 1994 45 : 1113 1119.
21. Schluter KD, Piper HM. Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide. Cardiovasc Res 1998 37 : 34 41.
22. Saleh FN, Schirmer H, Sundsfjord J, Jorde R. Parathyroid hormone and left ventricular hypertrophy. Eur Heart J 2003 24 : 054 060.
23. McGonigle RJ, Fowler MB, Timmis AB, Weston MJ, Parsons V. Uremic cardiomyopathy: potential role of vitamin D and parathyroid hormone. Nephron 1984 36 : 94 100.
24. Sato S, Ohta M, Kawaguchi Y, et al. Effects of parathyroidectomy on left ventricular mass in patients with hyperparathyroidism. Miner Electrolyte Metab 1995 21 : 67 71.
25. Singh NP, Sahni V, Garg D, Nair M. Effect of pharmacological suppression of secondary hyperparathyroidism on cardiovascular hemodynamics in predialysis ckd patients: a preliminary observation. Hemodial Int 2007 11 : 417 423.
26. Nappi S, Saha H, Virtanen V, Limnell V, Sand J, Salmi J, Pasternack A. Left ventricular structure and function in primary hyperparathyroidism before and after parathyroidectomy. Cardiology 2000 93 : 229 233.
27. Drueke T, Fauchet M, Fleury J, Lesourd P, Toure Y, Le Pailleur C, de Vernejoul P, Crosnier J. Effect of parathyroidectomy on left-ventricular function in haemodialysis patients. Lancet 1980 1 : 112 114.
28. Hara S, Ubara Y, Arizono K, Ikeguchi H, Katori H, Yamada A, Ogura Y, Murata H, Mimura N. Relation between parathyroid hormone and cardiac function in long-term hemodialysis patients. Miner Electrolyte Metab 1995 21 : 72 6.
29. Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet 1998 351 : 805 806.
30. Holick MF. Vitamin D deficiency. N Engl J Med 2007 357 : 266 281.
31. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006 84 : 18 28.
32. Holick MF. The vitamin D epidemic and its health consequences. J Nutr 2005 135 : 2739S 48S.
33. Moulas A, Challa A, Chaliasos N, Lapatsanis PD. Vitamin D metabolites (25-hydroxyvitamin D, 24,25-dihydroxyvitamin D and 1,25-dihydroxyvitamin D) and osteocalcin in beta-thalassaemia. Acta Paediatr 1997 86 : 594 599.
34. Napoli N, Carmina E, Bucchieri S, Sferrazza C, Rini GB, Di Fede G. Low serum levels of 25-hydroxy vitamin D in adults affected by thalassemia major or intermedia. Bone 2006 38 : 888 892.
35. Tsitoura S, Amarilio N, Lapatsanis P, Pantelakis S, Doxiadis S. Serum 25-hydroxyvitamin D levels in thalassaemia. Arch Dis Child 1978 53 : 347 348.
36. Aloia JF, Ostuni JA, Yeh JK, Zaino EC. Combined vitamin D parathyroid defect in thalassemia major. Arch Intern Med 1982 142 : 831 832.
37. Dandona P, Menon RK, Houlder S, Thomas M, Hoffbrand AV, Flynn DM. Serum 1,25 dihydroxyvitamin D and osteocalcin concentrations in thalassaemia major. Arch Dis Child 1987 62 : 474 477.
38. Voskaridou E, Cyrtosis MC, Tempos E, Sordini M, Theodoropoulos I, Bergele A, Diamanti E, Kalovidouris A, Loutradi A, Loukopoulos D. Bone resorption is increased in young adults with thalassaemia major. Br J Haematol 2001 112 : 36 41.
39. Stamp TC, Round JM. Seasonal changes in human plasma levels of 25-hydroxyvitamin D. Nature 1974 247 : 563 565.
40. Lips P. Relative value of 25(oh)d and 1,25(oh)2d measurements. J Bone Miner Res 2007 22 : 1668 1671.
41. +)-sensing receptor from bovine parathyroid. Nature 1993 366 : 575 580.
42. Hass GM, Trueheart RE, Taylor CB, Stumpe M. An experimental histologic study of hypervitaminosis d. Am J Pathol 1958 34 : 395 431.
43. Niederhoffer N, Lartaud-Idjouadiene I, Giummelly P, Duvivier C, Peslin R, Atkinson J. Calcification of medial elastic fibers and aortic elasticity. Hypertension 1997 29 : 999 1006.